Elucidating the mechanisms by which bis(thiosemicarbazone)-copper complexes protect neurons in models of neurodegenerative diseases

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1054325

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Dr Liddell is a neuroscientist investigating potential therapeutic agents for the treatment of diseases of affecting the brain such as Alzheimer’s disease and Parkinson’s disease. He is examining a class of metal-based compounds that are showing strong potential for disease treatment, and is investigating how these compounds work. The findings will be used to further develop and improve these therapeutic agents, and may help understand the underlying causes of these diseases.

Funded Activity Details

Start Date: 01-01-2013

End Date: 01-01-2017

Funding Scheme: Early Career Fellowships

Funding Amount: $353,377.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Cellular Nervous System

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Alzheimer disease | amyotrophic lateral sclerosis | cell culture | copper | glutathione | neurodegenerative disorders | neuron-glia interactions | neuroprotection | novel therapeutic agents | signalling pathways

Related Links